Socioeconomic and medical determinants of state‐level subjective cognitive decline in the United States
Open Access
- 1 October 2024
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (11) , 7567-7579
Abstract
INTRODUCTION: It is important to understand the socioeconomic and medical determinants of subjective cognitive decline (SCD) at a population level in the United States.METHODS: The primary outcomes are state‐level rates of SCD and SCD‐related functional impairment in adults aged ≥ 45, both measured in the Behavioral Risk Factor Surveillance System from 2016 to 2022. The exposures are state‐level rates of poverty, unemployment, homelessness, college education, racial and ethnic minorities, uninsurance, smoking, hypertension, diabetes, and obesity as well as household income and physician density.RESULTS: The strongest state‐level associations with rates of SCD were the prevalence of diabetes (rho = 0.64), hypertension (rho = 0.59), and poverty (rho = 0.58; all p < 0.001), and with SCD‐related functional impairment were prevalence of poverty (rho = 0.71), diabetes (rho = 0.68), and hypertension (rho = 0.53; all p < 0.001).DISCUSSION: This study highlights critical links between SCD and socioeconomic and medical determinants in adults aged ≥ 45 in the United States, including the prevalence of poverty, diabetes, and hypertension.Highlights: State‐level analysis reveals socioeconomic and medical risk factors for subjective cognitive decline (SCD) at a population level. The prevalence of poverty is a critical contributor to the state‐level prevalence of SCD. The prevalence of diabetes and hypertension are also strong state‐level determinants of SCD. Addressing the burden of cognitive decline at the population level necessitates targeting socioeconomic and medical factors.Keywords
This publication has 57 references indexed in Scilit:
- Dementia Risk and Disadvantaged NeighborhoodsJAMA Neurology, 2023
- Pathways explaining racial/ethnic disparities in incident all‐cause dementia among middle‐aged US adultsAlzheimer's & Dementia, 2023
- Midlife vascular risk factors and risk of incident dementia: Longitudinal cohort and Mendelian randomization analyses in the UK BiobankAlzheimer's & Dementia, 2021
- Trends in Cardiovascular Disease Prevalence by Income Level in the United StatesJAMA Network Open, 2020
- Association of Neighborhood-Level Disadvantage With Alzheimer Disease NeuropathologyJAMA Network Open, 2020
- Prevalence of Multiplicity and Appropriate Adjustments Among Cardiovascular Randomized Clinical Trials Published in Major Medical JournalsJAMA Network Open, 2020
- Longitudinal Associations Between Income Changes and Incident Cardiovascular DiseaseJAMA Cardiology, 2019
- Health and Socioeconomic Inequities as Contributors to Brain HealthJAMA Neurology, 2019
- The Effects of Poverty on Childhood Brain DevelopmentJAMA Pediatrics, 2013
- Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer DiseaseArchives of Neurology, 2005